Abstract
Dopamine transporter (DAT) levels vary in normal subjects and deviate from the normal range in pathological states. We investigated mechanisms by which the DAT gene may influence DAT protein expression. As the 3′-untranslated region (3′-UTR) of the DAT gene varies with regard to length and single nucleotide polymorphisms (SNPs), we addressed whether the 3′-UTR of sequence-defined DAT alleles can differentially affect the level of reporter gene expression in vitro. We first established that within individual rhesus monkeys, two alleles of the DAT gene were expressed in the substantia nigra. We then transfected HEK-293 cells with HSV-TK- and SV40-driven luciferase expression vectors harboring downstream DAT 3′-UTR segments of alleles containing polymorphisms of length (human: 9 or 10 repeat units) or SNPs within alleles of fixed length (human: DraI-sensitive (DraI+) vs DraI-insensitive (DraI−) 10-repeat alleles; rhesus monkey: Bst1107I-sensitive (Bst+) vs Bst1107I-insensitive (Bst−) 12-repeat alleles). Vectors containing the 3′-UTR segment of a human DAT allele containing nine tandem repeat units resulted in significantly higher levels of luciferase production than analogous vectors containing 10 tandem repeat units. Depending on the promoter used, vectors containing the human or monkey 3′-UTR segments that differed on the basis of an SNP resulted in increases or decreases in luciferase gene expression. This report provides experimental evidence that variability in the length or the sequence of the 3′-UTR of the DAT gene may influence levels of DAT protein in the brain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shimada S, Kitayama S, Lin CL, Patel A, Nanthakumar E, Gregor P et al. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA Science 1991 254: 576–578
Kilty JE, Lorang D, Amara SG . Cloning and expression of a cocaine-sensitive rat dopamine transporter Science 1991 254: 578–579
Iversen L . Neurotransmitter transporters: fruitful targets for CNS drug discovery Mol Psychiatry 2000 5: 357–362
Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH et al. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease Ann Neurol 1993 34: 423–431
Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS et al. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients J Nucl Med 1998 39: 1500–1508
Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR et al. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters Synapse 1998 29: 128–141
Volkow ND, Fowler JS, Wang GJ, Logan J, Schlyer D, MacGregor R et al. Decreased dopamine transporters with age in healthy human subjects Ann Neurol 1994 36: 237–239
Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, Kapatos G . Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age Proc Natl Acad Sci USA 1992 89: 7095–7099
Kaufman MJ, Madras BK . Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum Synapse 1991 9: 43–49
Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY et al. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain Synapse 1998 29: 116–127
Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo Proc Natl Acad Sci U S A 1996 93: 5539–5543
Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ . Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 1999 354: 2132–2133
Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K . Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett 2000 285: 107–110
Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF et al. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment Eur J Nucl Med 2000 27: 1518–1524
Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP et al. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder Am J Psychiatry 1995 152: 1359–1361
Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J . Striatal dopamine transporter density in major depression Psychopharmacology (Berl) 1999 144: 282–285
Bowers MB Jr, Malison RT, Seibyl JP, Kosten TR . Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal Biol Psychiatry 1998 43: 278–281
White FJ, Hu X-T, Henry DJ, Zhang X-F . Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration. In: Hammer RJ Jr (ed) The Neurobiology of Cocaine: Cellular and Molecular Mechanisms CRC Press: Boca Raton, FL 1995 pp 99–119
Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nature Med 1996 2: 699–703
Fleckenstein AE, Metzger RR, Gibb JW, Hanson GR . A rapid and reversible change in dopamine transporters induced by methamphetamine Eur J Pharmacol 1997 323: R9–10
Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY . Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain Brain Res 1982 235: 93–103
Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD et al. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations Mol Psychiatry 2000 5: 283–292
Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M et al. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) Mol Psychiatry 2000 5: 275–282
Morino H, Kawarai T, Izumi Y, Kazuta T, Oda M, Komure O et al. A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease Ann Neurol 2000 47: 528–531
Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 1992 14: 1104–1106
Doucette-Stamm LA, Blakely DJ, Tian J, Mockus S, Mao JI . Population genetic study of the human dopamine transporter gene (DAT1) Genet Epidemiol 1995 12: 303–308
Kang AM, Palmatier MA, Kidd KK . Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3) Biol Psychiatry 1999 46: 151–160
Mitchell RJ, Howlett S, Earl L, White NG, McComb J, Schanfield MS et al. Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations Hum Biol 2000 72: 295–304
Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 1995 56: 993–998
Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M . Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Mol Psychiatry 1997 2: 311–313
Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity Am J Hum Genet 1998 63: 1767–1776
Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry 1999 4: 192–196
Winsberg BG, Comings DE . Association of the dopamine transporter gene (DAT1) with poor methylphenidate response J Am Acad Child Adolesc Psychiatry 1999 38: 1474–1477
Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL et al. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder Mol Psychiatry 2000 5: 523–530
Gelernter J, Kranzler HR, Satel SL, Rao PA . Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 1994 11: 195–200
Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium Biol Psychiatry 1997 41: 299–304
Franke P, Schwab SG, Knapp M, Gansicke M, Delmo C, Zill P et al. DAT1 gene polymorphism in alcoholism: a family-based association study Biol Psychiatry 1999 45: 652–654
Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al. Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 2000 22: 133–139
Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T . Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene Am J Psychiatry 1998 155: 474–478
Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B et al. Evidence suggesting the role of specific genetic factors in cigarette smoking Health Psychol 1999 18: 14–20
Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S et al. A genetic association for cigarette smoking behavior Health Psychol 1999 18: 7–13
Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B et al. Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey Am J Med Genet 2000 96: 331–334
Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report Am J Psychiatry 2000 157: 1700–1703
Miller GM, De La Garza R, Novak M, Madras BK . Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders Mol Psychiatry 2001 6: 50–58
Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T et al. Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism Mol Psychiatry 1999 4: 552–557
Giros B, Caron MG . Molecular characterization of the dopamine transporter Trends Pharmacol Sci 1993 14: 43–49
Blakely RD, Bauman AL . Biogenic amine transporters: regulation in flux Curr Opin Neurobiol 2000 10: 328–336
Higuchi S, Muramatsu T, Arai H, Hayashida M, Sasaki H, Trojanowski JQ . Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease J Neural Transm Park Dis Dement Sect 1995 10: 107–113
Le Couteur DG, Leighton PW, McCann SJ, Pond S . Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease Mov Disord 1997 12: 760–763
Mercier G, Turpin JC, Lucotte G . Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found J Neurol 1999 246: 45–47
Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G et al. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode Am J Med Genet 1996 67: 406–408
Persico AM, Macciardi F . Genotypic association between dopamine transporter gene polymorphisms and schizophrenia Am J Med Genet 1999 74: 53–57
Persico AM, Catalano M . Lack of association between dopamine transporter gene polymorphisms and delusional disorder Am J Med Genet 1998 81: 163–165
Persico AM, Vandenbergh DJ, Smith SS, Uhl GR . Dopamine transporter gene polymorphisms are not associated with polysubstance abuse Biol Psychiatry 1993 34: 265–267
Parsian A, Zhang ZH . Human dopamine transporter gene polymorphism (VNTR) and alcoholism Am J Med Genet 1997 74: 480–482
Lewczyk CM, Fernandez T, Castellanos FX, Koprivica V, Kashani A, Tayebi N et al. Lack of association between dopamine transporter (DAT1) and ADHD Biol Psychiatry 1999 45: 845
Jackson RJ . Cytoplasmic regulation of mRNA function: the importance of the 3′ untranslated region Cell 1993 74: 9–14
Decker CJ, Parker R . Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts Curr Opin Cell Biol 1995 7: 386–392
Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J et al. The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample Neurosci Lett 2001 297: 125–128
Nakamura M, Ueno S, Sano A, Tanabe H . The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants Mol Psychiatry 2000 5: 32–38
Miller GM, Yatin SM, De La GR, Goulet M, Madras BK . Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity Brain Res Mol Brain Res 2001 87: 124–143
Yatin SM, Miller GM, Goulet M, Alvarez X, Madras BK . Cocaine and dopamine: differential effects on dopamine transporter distribution Soc Neurosci Abs 2000 26: 17.9
Li X, Rhode SL III . The parvovirus H-1 NS2 protein affects viral gene expression through sequences in the 3′-untranslated region Virology 1993 194: 10–19
Vadher S, Hawa NS, O'Riordan JL, Farrow SM . Translational regulation of parathyroid hormone gene expression and RNA: protein interactions J Bone Miner Res 1996 11: 746–753
Lazarov ME, Martin MM, Willardson BM, Elton TS . Human phosducin-like protein (hPhLP) messenger RNA stability is regulated by cis-acting instability elements present in the 3′-untranslated region Biochim Biophys Acta 1999 1446: 253–264
Stuart JJ, Egry LA, Wong GH, Kaspar RL . The 3′ UTR of human MnSOD mRNA hybridizes to a small cytoplasmic RNA and inhibits gene expression Biochem Biophys Res Commun 2000 274: 641–648
Ashley WW Jr, Russell B . Tenotomy decreases reporter protein synthesis via the 3′-untranslated region of the beta-myosin heavy chain mRNA Am J Physiol Cell Physiol 2000 279: C257–C265
Madras BK, Jones AG, Mahmood A, Zimmerman RE, Garada B, Holman BL et al. Technepine: a high-affinity 99m-technetium probe to label the dopamine transporter in brain by SPECT imaging Synapse 1996 22: 239–246
Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease Proc Natl Acad Sci USA 1993 90: 11965–11969
Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes—DRD2, D beta H, and DAT1 Am J Med Genet 1996 67: 264–288
Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H et al. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes Clin Genet 2000 57: 178–196
Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H et al. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder Clin Genet 2000 58: 31–40
Chan PT, Lebowitz J . Site-directed mutagenesis of the −10 region of the lacUV5 promoter. Introduction of dA4.dT4 tract suppresses open complex formation J Biol Chem 1990 265: 4091–4097
Cowley GS, Murthy AE, Parry DM, Schneider G, Korf B, Upadhyaya M et al. Genetic variation in the 3′ untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression Somat Cell Mol Genet 1998 24: 107–119
Rotondaro L, Mele A, Rovera G . Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3′-untranslated sequences Gene 1996 168: 195–198
Acknowledgements
We thank Dina Yang for excellent technical assistance and Sandra Talbot for manuscript preparation. Grant numbers: NIDA-NIH: DA11558 (BKM); DA06303 (BKM); NINDS: NS30556 (BKM); NIDA DA00304 (BKM); NCRR: RR00168 (NERPRC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miller, G., Madras, B. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7, 44–55 (2002). https://doi.org/10.1038/sj.mp.4000921
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000921
Keywords
This article is cited by
-
Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women
Purinergic Signalling (2023)
-
Disordered eating in early childhood: DRD4 and DAT1 gene polymorphisms and quality of mother–child interaction
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2022)
-
Association of serotonin system-related genes with homicidal behavior and criminal aggression in a prison population of Pakistani Origin
Scientific Reports (2021)
-
The nucleus accumbens and ventral pallidum exhibit greater dopaminergic innervation in humans compared to other primates
Brain Structure and Function (2021)
-
Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder
Journal of Neural Transmission (2019)